Cargando…
驱动基因阳性肺癌脑转移患者的靶向治疗进展
Brain is the most common site of lung cancer metastasis, and the incidenceis are higher if patients have driver gene mutation. Patients with brain metastasis have a poor prognosis; further, different treatment methods affect the disease status and prognosis. In recent years, with the development of...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885421/ https://www.ncbi.nlm.nih.gov/pubmed/31771742 http://dx.doi.org/10.3779/j.issn.1009-3419.2019.11.06 |
Ejemplares similares
-
非小细胞肺癌脑转移靶向治疗研究进展
Publicado: (2014) -
驱动基因阴性非小细胞肺癌脑转移免疫治疗的研究进展
Publicado: (2018) -
非小细胞肺癌驱动基因突变及靶向治疗的研究进展
Publicado: (2014) -
晚期非小细胞肺癌ALK融合基因及其他少见驱动基因阳性靶向治疗进展
Publicado: (2017) -
驱动基因阳性肺腺癌在靶向治疗中病理类型转化的机制与治疗策略
Publicado: (2020)